Arcus Biosciences
+$0.75 (+2.21%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours
Why Robinhood?
You can buy or sell RCUS and other stocks, options, and ETFs commission-free!
About RCUS
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer.
CEO
Terry J. Rosen
Employees
236
Headquarters
Hayward, California
Founded
2015
Market Cap
2.55B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
513.35K
High Today
$34.95
Low Today
$32.81
Open Price
$33.75
Volume
408.76K
52 Week High
$42.36
52 Week Low
$16.69
Analyst Ratings
90%
of 10 ratings
Buy
90%
Hold
10%
Sell
0%
RCUS Earnings
-$0.93
-$0.60
-$0.28
$0.05
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 29, After Hours